Nomura Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-49,842
Closed -$9.16M 1342
2021
Q2
$9.16M Buy
49,842
+3,108
+7% +$571K 0.05% 335
2021
Q1
$7.15M Buy
46,734
+1,160
+3% +$177K 0.05% 371
2020
Q4
$7.12M Buy
45,574
+1,362
+3% +$213K 0.05% 335
2020
Q3
$5.06M Buy
44,212
+2,161
+5% +$247K 0.04% 376
2020
Q2
$4.72M Buy
42,051
+472
+1% +$53K 0.04% 370
2020
Q1
$3.73M Sell
41,579
-13,011
-24% -$1.17M 0.04% 377
2019
Q4
$5.9M Buy
54,590
+15,335
+39% +$1.66M 0.05% 317
2019
Q3
$3.85M Buy
39,255
+2,201
+6% +$216K 0.04% 399
2019
Q2
$4.85M Sell
37,054
-751
-2% -$98.4K 0.05% 325
2019
Q1
$5.11M Sell
37,805
-578
-2% -$78.1K 0.05% 315
2018
Q4
$3.74M Buy
38,383
+2,644
+7% +$257K 0.04% 350
2018
Q3
$4.97M Buy
35,739
+1,306
+4% +$182K 0.05% 305
2018
Q2
$4.28M Buy
34,433
+653
+2% +$81.1K 0.04% 323
2018
Q1
$3.77M Buy
33,780
+2,079
+7% +$232K 0.04% 342
2017
Q4
$3.79M Sell
31,701
-16,740
-35% -$2M 0.04% 332
2017
Q3
$6.8M Buy
48,441
+1,207
+3% +$169K 0.09% 216
2017
Q2
$5.75M Buy
47,234
+1,524
+3% +$185K 0.08% 241
2017
Q1
$5.54M Buy
45,710
+708
+2% +$85.8K 0.08% 257
2016
Q4
$5.51M Buy
45,002
+7,547
+20% +$924K 0.1% 231
2016
Q3
$4.59M Buy
37,455
+477
+1% +$58.4K 0.08% 253
2016
Q2
$4.32M Sell
36,978
-265
-0.7% -$30.9K 0.08% 252
2016
Q1
$5.19M Buy
37,243
+12,023
+48% +$1.67M 0.1% 215
2015
Q4
$4.81M Sell
25,220
-5,222
-17% -$996K 0.09% 222
2015
Q3
$4.76M Buy
30,442
+5,596
+23% +$875K 0.1% 219
2015
Q2
$4.49M Buy
24,846
+2,417
+11% +$437K 0.08% 234
2015
Q1
$3.89M Sell
22,429
-3,423
-13% -$593K 0.07% 257
2014
Q4
$4.78M Sell
25,852
-772
-3% -$143K 0.08% 234
2014
Q3
$4.42M Buy
26,624
+237
+0.9% +$39.3K 0.08% 238
2014
Q2
$4.12M Buy
26,387
+1,322
+5% +$207K 0.08% 248
2014
Q1
$3.81M Buy
25,065
+4,105
+20% +$624K 0.07% 263
2013
Q4
$2.79M Sell
20,960
-6,060
-22% -$805K 0.05% 317
2013
Q3
$3.14M Buy
27,020
+4,330
+19% +$503K 0.06% 296
2013
Q2
$2.09M Buy
+22,690
New +$2.09M 0.04% 393